Breast carcinoma: expected results with prevailing therapy.
Computer-stored tumor registry data were scanned to produce the set of patients whose breast carcinoma was either diagnosed or first treated at Evanston Hospital between the years 1973 and 1977, inclusive. Of 560 evaluable patients, 184 were less than or equal to age 50 (LE 50), and 376 were greater than age 50 (GT 50). Comparisons of projected survival show that the survival of all patients is 8% at 5 years and 72% at 7 years. The survival of patients LE 50 is nearly identical to that of the GT 50 age group. Survival of Stage III GT 50 patients, however, is better than Stage III LE 50 (P less than 0.001). Comparison with earlier studies shows an historical trend toward better 5-year survival. Data were generated in this study which allow prediction of prognosis based upon age and stage at diagnosis.
D000367:Age Factors; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D007087:Illinois; D009367:Neoplasm Staging; D011446:Prospective Studies; D012042:Registries; D012189:Retrospective Studies